When Telehealth Scale Collides With Patient Safety
The rush to digitize GLP-1 prescribing is exposing a dangerous rift between venture-backed growth targets and basic clinical caution.
July 21, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 💼 Health Entrepreneurship.
Tempus AI Buys Personalis for $1.5 Billion
A massive consolidation in cancer diagnostics reveals the steep financial price of dominating the liquid biopsy market.
July 21, 2026
London Cuts Red Tape for Clinical AI
A new regulatory fast-track aims to end the endless cycle of localized pilot programs that keep medical technology from reaching patients.
July 20, 2026
AI Drug Discovery Targets the Factory Floor
A new joint venture is shifting AI’s role from designing molecules to actually building them at scale.
July 17, 2026
Neko Health Bets $700 Million on Preventive Scans
A massive investment in full-body scanning reveals a fundamental shift toward startups that build their own clinical data from scratch.
July 16, 2026
Chai Discovery Hits Three Billion Dollar Valuation
A massive new funding round for an AI drug startup shows that Big Pharma is outsourcing its most critical early-stage molecular design.
July 14, 2026
Canada Pours Millions Into Hospital Data
A massive cash injection for Canada’s clinical data platform exposes the deep friction between sovereign AI ambitions and fragmented provincial healthcare systems.
July 13, 2026
Evernorth Bets $100 Million on AI Pharmacy
Specialty drug costs are eating health insurance budgets alive, forcing payers to automate the back office just to survive the margin squeeze.
July 12, 2026
Turning Failed Clinical Trials Into AI Models
Biotech companies are finding a second life for failed drug data, but recycling bad trials into predictive algorithms carries hidden risks.
July 12, 2026
IKS Health Bets Big on Rural Tech
A massive debt-funded acquisition reveals how AI vendors must buy their way into legacy hospital workflows.
July 10, 2026